E-cigarette efficacy for smoking cessation

Medical discussions regarding the efficacy of e-cigarettes for smoking cessation have gained momentum through new clinical guidelines and large-scale research.

Initially, guidelines published in the medical journal JAMA recommended that e-cigarettes be used as a tool for smoking cessation, comparable to other nicotine replacement therapies. These recommendations, developed by experts from the Society for Research on Nicotine and Tobacco, noted that e-cigarettes may be more effective than traditional patches, gums, or lozenges because they avoid tobacco combustion and significantly reduce exposure to carcinogens.

An updated Cochrane review, analyzing 80 randomized controlled trials involving nearly 30,000 participants across the US, UK, and Australia, has reinforced these findings. The review indicates that nicotine-containing e-cigarettes result in an 8 to 10 percent success rate for smoking abstinence over at least six months. This represents an approximate 60% increase in success compared to traditional nicotine replacement therapies (NRT) and non-nicotine vapes, which reach a maximum success rate of approximately six percent. Behavioral support alone resulted in roughly five per 100 people remaining smoke-free.

Researchers, including Dr. Nicola Lindson of the University of Oxford and Dr. Jamie Hartmann-Boyce of the University of Massachusetts, noted that while nicotine vapes are ‘unlikely to be completely risk-free,’ they are ‘less harmful than smoking.’ Experts emphasized that these findings apply to regulated, quality-checked devices and cautioned against the use of unlicensed or illegal e-cigarettes, which may contain harmful chemicals or have unstable batteries. While no immediate evidence of serious harm was found, researchers noted that long-term risks remain unclarified and require further study.